O
Omnicell, Inc.
OMCL · NASDAQ · Healthcare · 1.7B
Price · close
$35.58
+0.23% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
797.0×
Price / net assetsP/B
1.3×
Enterprise value / EBITDAEV/EBITDA
16.1×
Free cash flow yieldFCF yield
5.3%
Return on equityROE
0.2%
Operating margin
1.0%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
3.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.